RMFCX
Price
$61.63
Change
-$0.55 (-0.88%)
Updated
Jun 10 closing price
Net Assets
116.64B
VYCBX
Price
$27.52
Change
-$0.36 (-1.29%)
Updated
Jun 10 closing price
Net Assets
1.33B
Interact to see
Advertisement

RMFCX vs VYCBX

Header iconRMFCX vs VYCBX Comparison
Open Charts RMFCX vs VYCBXBanner chart's image
RMFCX vs VYCBX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. VYCBX commentary
Jun 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and VYCBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 117B vs. VYCBX (1.33B). RMFCX pays higher dividends than VYCBX: RMFCX (1.19) vs VYCBX (0.58). RMFCX was incepted earlier than VYCBX: RMFCX (24 years) vs VYCBX (18 years). VYCBX (1.62) is less costly to investors than RMFCX (0.91). RMFCX (30.00) and VYCBX (29.00) have comparable annual turnover. RMFCX has a lower initial minimum investment than VYCBX: RMFCX (250) vs VYCBX (1000). RMFCX (9.29) and VYCBX (9.10) have marching annual gain over last year. RMFCX return over 5 years is better than : 33.94 vs. VYCBX (26.66).
RMFCXVYCBXRMFCX / VYCBX
Total Expense Ratio0.911.3766%
Annual Report Gross Expense Ratio0.911.6256%
Fund Existence24 years18 years-
Gain YTD6.3406.091104%
Front LoadN/AN/A-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets117B1.33B8,810%
Annual Yield % from dividends1.190.58206%
Returns for 1 year9.299.10102%
Returns for 3 years34.4737.9391%
Returns for 5 years33.9426.66127%
Returns for 10 years93.2271.01131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWAX100.062.93
+3.02%
American Funds New World R1
GSMAX20.46N/A
N/A
Goldman Sachs Small/Mid Cap Growth A
EISGX15.98N/A
N/A
Eaton Vance Small-Cap I
TRHBX29.58N/A
N/A
Nuveen Small Cap Blend Idx I
UEMPX12.31N/A
N/A
UBS Emerging Markets Equity Opp P